PFE: Reports Phase 3 Results
Pfizer announces topline Phase 3 results for Sigvotatug Vedotin in previously treated metastatic non-squamous non-small cell lung cancer
PFE - Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer